High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS) responsive to weekly paclitaxel (P) and trastuzumab (T) treatment. 5 National Congress of Medical Oncology, Rome, 21-24 October 2003.

High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS) responsive to weekly paclitaxel (P) and trastuzumab (T) treatment. 5 National Congress of Medical Oncology, Rome, 21-24 October 2003 / Gori, S.; Aristei, Cynthia; Mosconi, A.; Cherubini, R.; Basurto, C.; Colozza, M.; Roila, F.; De Angelis, V.; Latini, Paolo; Tonato, M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - :14 (suppl. 4)(2003).



Titolo: High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS) responsive to weekly paclitaxel (P) and trastuzumab (T) treatment. 5 National Congress of Medical Oncology, Rome, 21-24 October 2003.
Autori: 
ARISTEI, Cynthia
Roila, Fausto
LATINI, Paolo
mostra contributor esterni 
Data di pubblicazione: 2003
Rivista: 
ANNALS OF ONCOLOGY  
Handle: http://hdl.handle.net/11391/23730
Appare nelle tipologie:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11391/23730
  • Citazioni
  • PubMed Central ND
  • Scopus ND
  • WOS ND

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020